Recent developments have shed light on the ongoing investigation into the tragic death of actor Matthew Perry. The Los Angeles Police Department (LAPD) is conducting a criminal investigation following Perry's untimely demise last October. The medical examiner's report attributed his death to the acute effects of ketamine, a powerful anesthetic.
Authorities have revealed that two federal agencies, namely the Drug Enforcement Administration (DEA) and the United States Postal Service, have joined forces with the LAPD in a joint effort to uncover the circumstances surrounding Perry's death. The focus of their investigation is centered on determining the origin of the ketamine found in Perry's system at the time of his passing.
Perry had been undergoing ketamine infusion therapy to manage his anxiety and depression, with his last treatment occurring approximately a week and a half before his death. Despite the typical elimination timeline for ketamine from the body, the autopsy report indicated a significantly elevated level of the substance in Perry's system at the time of his demise.
The collaborative investigative team is diligently working to trace the source of the ketamine and identify the individuals responsible for supplying the drug to Perry. While the LAPD has confirmed that the investigation is of a criminal nature and suggests potential criminal liability, specific details regarding the case have not been disclosed to the public at this time.
As the investigation unfolds, authorities are committed to unraveling the circumstances surrounding Matthew Perry's death and ensuring accountability for any wrongdoing that may have contributed to the tragic event. The involvement of multiple law enforcement agencies underscores the seriousness and complexity of the case, highlighting the importance of a thorough and meticulous inquiry into the matter.
